Showing results (101-110 of 131) with videos related to
Sort By:
Pageof 14
Proceedings of the National Academy of Sciences of the United States of America|April 3, 2010
Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulationHarald M H G Albers, Anping Dong, Laurens A van Meeteren, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 18, 2010
Rapid and robust transgenic high-grade glioma mouse models for therapy intervention studiesNienke A de Vries, Sophia W Bruggeman, Danielle Hulsman, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 23, 2009
Functionally overlapping roles of Abcg2 (Bcrp1) and Abcc2 (Mrp2) in the elimination of methotrexate and its main toxic metabolite 7-hydroxymethotrexate in vivoMaria L H Vlaming, Zeliha Pala, Anita van Esch, et al.Molecular Cancer|June 3, 2024
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patientsXiaohang Qiao, Sabina Y van der Zanden, Xiaoyang Li, et al.Cancer Research|November 19, 2009
Absence of both cytochrome P450 3A and P-glycoprotein dramatically increases docetaxel oral bioavailability and risk of intestinal toxicityRobert A B van Waterschoot, Jurjen S Lagas, Els Wagenaar, et al.Cancer Research|October 3, 2013
Crizotinib inhibits metabolic inactivation of gemcitabine in c-Met-driven pancreatic carcinomaAmir Avan, Viola Caretti, Niccola Funel, et al.The EMBO Journal|September 17, 2019
SLC1A3 contributes to L-asparaginase resistance in solid tumorsJianhui Sun, Remco Nagel, Esther A Zaal, et al.Cell Reports|March 31, 2023
Drug-repurposing screen on patient-derived organoids identifies therapy-induced vulnerability in KRAS-mutant colon cancerSander Mertens, Maarten A Huismans, Carla S Verissimo, et al.Proceedings of the National Academy of Sciences of the United States of America|July 13, 2007
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancerSven Rottenberg, Anders O H Nygren, Marina Pajic, et al.Nature Communications|June 24, 2020
Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumoursJoão M Fernandes Neto, Ernest Nadal, Evert Bosdriesz, et al.Pageof 14